Silverback Therapeutics (SBTX) Stock Chart & Stock Price History $17.38 +0.20 (+1.16%) As of 08/4/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock Silverback Therapeutics Stock Price Performance The Silverback Therapeutics (SBTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 77.71%, with a year-to-date return of 63.65%. In the past month, the stock has increased 3.76%, reflecting recent market activity. As of the latest close, Silverback Therapeutics traded at $17.38 with a market cap of $626.69 million and volume of 1.20 million shares. Receive SBTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.70%1 Month Performance+3.76%3 Month Performance+21.88%Year-To-Date Performance+63.65%1 Year Performance+77.71% SBTX Stock Chart for Wednesday, August, 6, 2025 SBTX Chart by TradingView Silverback Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/05/2025$17.18$17.38+1.16%$17.62$17.081.20 million shs$626.69 million08/04/2025$17.18$17.18$17.70$17.071.18 million shs$619.48 million08/01/2025$17.88$17.68-1.12%$17.91$17.511.09 million shs$211.66 million07/31/2025$17.75$17.88+0.73%$18.42$17.731.11 million shs$644.72 million07/30/2025$18.35$17.75-3.27%$18.50$17.70728,720 shs$640.03 million07/29/2025$17.87$18.35+2.69%$18.63$17.782.06 million shs$211.66 million07/28/2025$17.87$17.87$18.05$17.412.73 million shs$644.36 million07/25/2025$18.00$17.92-0.44%$18.16$17.701.29 million shs$646.16 million07/24/2025$17.59$18.00+2.33%$18.17$17.431.15 million shs$649.04 million07/23/2025$17.85$17.59-1.46%$18.00$17.52748,382 shs$634.26 million Get the Latest News and Ratings for SBTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/22/2025$17.92$17.85-0.39%$18.15$17.61718,053 shs$643.64 million07/21/2025$17.92$17.92$18.61$17.751.34 million shs$646.16 million07/18/2025$17.87$18.35+2.69%$18.44$17.751.81 million shs$661.66 million07/17/2025$17.56$17.87+1.77%$17.99$17.57900,453 shs$644.36 million07/16/2025$17.90$17.56-1.90%$18.00$17.19972,931 shs$633.18 million07/15/2025$17.69$17.90+1.19%$18.22$17.61926,955 shs$645.44 million07/14/2025$17.69$17.69$18.05$17.461.11 million shs$637.87 million07/11/2025$16.95$17.98+6.08%$18.05$17.291.43 million shs$648.32 million07/10/2025$16.95$16.95$17.44$16.401.30 million shs$611.18 million07/09/2025$17.09$16.95-0.82%$17.44$16.401.30 million shs$611.18 million07/08/2025$16.52$17.09+3.45%$17.90$16.441.66 million shs$616.23 million07/07/2025$16.52$16.52$16.81$16.15881,491 shs$595.68 million Related Companies MENS Stock Price Chart CALT Stock Price Chart ZYME Stock Price Chart MBX Stock Price Chart NLTX Stock Price Chart AVTE Stock Price Chart CYBN Stock Price Chart BIOA Stock Price Chart VIRI Stock Price Chart WHWK Stock Price Chart Receive SBTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SBTX) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silverback Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silverback Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBTX Stock Alerts